Exhibit 3.1.1
FIFTH AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
NEXIMMUNE, INC.
(Pursuant to Sections 242 and 245 of the
General Corporation Law of the State of Delaware)
NexImmune, Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the “General Corporation Law”),
DOES HEREBY CERTIFY:
1. That the name of this corporation is NexImmune, Inc., and that this corporation was originally incorporated pursuant to the General Corporation Law on June 7, 2011 under the name NexImmune, Inc. An Amended and Restated Certificate of Incorporation of NexImmune, Inc. was filed with the Secretary of State of the State of Delaware on January 10, 2017. A Second Amended and Restated Certificate of Incorporation of NexImmune, Inc. was filed with the Secretary of State of the State of Delaware on December 28, 2017. A Third Amended and Restated Certificate of Incorporation of NexImmune, Inc. was filed with the Secretary of State of the State of Delaware on December 28, 2017. A Fourth Amended and Restated Certificate of Incorporation of NexImmune, Inc. was filed with the Secretary of State of the State of Delaware on January 8, 2019. This Fifth Amended and Restated Certificate of Incorporation is hereby amended and restated, in its entirety, to, among other things, create a new class of preferred stock of NexImmune, Inc., as set forth below.
2. That the Board of Directors duly adopted resolutions proposing to amend and restate the Certificate of Incorporation, declaring said amendment and restatement to be advisable and in the best interests of this corporation and its stockholders, and authorizing the appropriate officers of this corporation to solicit the consent of the stockholders therefor, which resolution setting forth the proposed amendment and restatement is as follows:
RESOLVED, that this Fifth Amended and Restated Certificate of Incorporation amends and restates the Certificate of Incorporation in its entirety to read as follows:
FIRST: The name of this corporation is NexImmune, Inc. (the “Corporation”).
SECOND: The address of the registered office of the Corporation in the State of Delaware is 251 Little Falls Drive, Wilmington, Delaware, 19808, County of New Castle, and the name of its registered agent at such address is The Corporation Service Company.
THIRD: The nature of the business or purposes to be conducted or promoted is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law.
FOURTH: The total number of shares of all classes of stock which the Corporation shall have authority to issue is (i) 246,180,160 shares of Common Stock, $0.0001 par value per share (“Common Stock”) and (ii) an aggregate of 184,182,081 shares of Preferred Stock, $0.0001 par value per share (“Preferred Stock”).